Cumberland PharmaceuticalsCPIX
13F holders, Q3 2024 (September 30)22holders −1
2new positions
3sold out
1famous investor
$1.28avg. 13F price*
At the end of Q3 2024, 22 institutions reported holding Cumberland Pharmaceuticals (CPIX) in their 13F filings, down 1 from Q2 2024. 2 opened new positions and 3 sold out. The largest holders were Renaissance Technologies ($676K), Vanguard Group Inc. ($479K) and Bridgeway Capital Management, LLC ($367K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Cumberland Pharmaceuticals
- CUSIP
- 230770109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $13K |
| Exits | 3 | $3K |
All 13F filers, Q2 2024 → Q3 2024: 13,620 shares bought and 46,816 shares sold, net −33,196 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Renaissance Technologies | 0.00% | Reduce -1.9% | 528,163 | $676K |
| Vanguard Group Inc. | 0.00% | No change | 374,251 | $479K |
| Bridgeway Capital Management, LLC | 0.01% | No change | 286,655 | $367K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -6.6% | 284,005 | $364K |
| Acadian Asset Management LLC | 0.00% | No change | 188,164 | $239K |
| BlackRock, Inc. | 0.00% | — | 110,068 | $141K |
| Bank of New York Mellon Corp | 0.00% | No change | 75,268 | $96K |
| Geode Capital Management, LLC | 0.00% | Reduce -16.3% | 74,305 | $95K |
| State Street Corp. | 0.00% | No change | 33,700 | $43K |
| Cresset Asset Management, LLC | 0.00% | Add +1.2% | 21,275 | $27K |
| Two Sigma Investments, LP | 0.00% | Add +0.3% | 19,378 | $25K |
| Northern Trust Corp. | 0.00% | No change | 16,322 | $21K |
| Schonfeld Strategic Advisors LLC | 0.00% | New | 10,000 | $13K |
| UBS Group AG | 0.00% | Add +40.8% | 9,671 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -6.7% | 6,166 | $8K |
| Oakworth Capital, Inc. | 0.00% | No change | 3,052 | $4K |
| Morgan Stanley | 0.00% | No change | 2,660 | $3K |
| Wells Fargo & Company | 0.00% | New | 250 | $320 |
| JPMorgan Chase & Co. | 0.00% | Add +995.0% | 219 | $280 |
| Bank of America Corp. | 0.00% | Add +107.5% | 139 | $178 |
| Osaic Holdings, Inc. | 0.00% | No change | 100 | $128 |
| Huntington National Bank | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is CPIX's weight in each manager's 13F, not the share of Cumberland Pharmaceuticals the manager owns.